.svg)
If cancer has appeared in your family and you are wondering whether you should be tested, an inherited cancer risk panel is what you are usually directed toward. It is the most efficient and most informative way to find out whether you carry a gene mutation that could elevate your cancer risk.
An inherited cancer risk panel is a single genetic test that analyzes your DNA across multiple genes at the same time. From one cheek swab or blood sample, it can assess an increased risk for breast and ovarian cancer, colorectal cancer, melanoma, pancreatic cancer, and several other cancer types, all in one test, with one result, in 2 to 4 weeks. For individuals with a personal or family history of cancer, a hereditary cancer risk panel is the most efficient tool for understanding whether an inherited mutation is present. (NIH NHGRI, Genetic Testing)
This article explains what an inherited cancer risk panel actually does, which cancers and genes it covers, who should consider one, what the results mean, and what to do once you have them.
An inherited cancer risk panel analyzes the DNA you were born with to identify inherited gene mutations linked to elevated cancer risk. Unlike older approaches that tested for one gene at a time, a panel tests multiple genes simultaneously from a single sample. This is now considered the clinical standard for hereditary cancer risk assessment. (NCI, Genetic Testing Fact Sheet)
In the past, if a doctor suspected a specific hereditary cancer syndrome based on family history, they would order a single-gene test to check for it. If that came back negative, they might order another test for a different gene, then another, each adding to the cost and waiting time.
Multi-gene panel testing replaced this for two reasons:
First, many hereditary cancer mutations are linked to more than one cancer type, and a person's family history does not always point clearly to which gene to test. A woman whose family is mainly affected by breast cancer might test only for BRCA1 and BRCA2 and miss a PALB2 mutation that would also explain the pattern. A man worried about prostate cancer in his family might test for BRCA2 and discover a Lynch syndrome mutation that has implications for colorectal cancer, too. Multi-gene panel testing catches what targeted testing misses.
Second, the cost and accuracy of multi-gene panel testing have improved dramatically. A modern panel covers 25 to 35 genes, or more, for roughly the same cost as testing one or two genes a decade ago, with the same level of clinical accuracy.
A comprehensive inherited cancer risk panel typically covers genes linked to the following cancer types:
The exact genes included in a panel vary by laboratory. A genetic counselor, who is a specialist trained to assess hereditary cancer risk, helps determine which panel makes the most sense for you based on your personal and family history.
Genetic testing is usually recommended based on a person's personal and family medical history. Depending on the healthcare setting, a physician or genetic counselor may review these factors, discuss whether testing is appropriate, and explain what the results could mean before testing begins.
DNA is collected through a cheek swab, saliva sample, or blood draw. The sample is sent to a CAP-accredited, CLIA-certified laboratory, which meets the quality standards required for clinical testing and decision-making. The lab analyzes the specific genes included in the test panel to look for variants, or differences from the expected genetic sequence, and classifies them based on the available scientific evidence.
Results are returned to your genetic counselor, who reviews them with you in the context of your personal and family history. This is where results are interpreted, not just reported. If a result is positive, your counselor explains what it may mean, reviews recommended next steps, and works with your physician to coordinate appropriate monitoring or risk-reduction options. Your genetic information is private and protected, accessible only to you and your care team.
Results from an inherited cancer risk panel typically fall into two main categories:
A harmful inherited gene mutation was identified. This is an actionable finding. It does not mean cancer is certain. It means your lifetime risk for the associated cancer types is significantly elevated, and that clinical guidelines recommend specific monitoring or prevention steps.
No harmful inherited gene mutation was found in the genes tested. This substantially reduces the likelihood of a hereditary cancer syndrome. It does not eliminate cancer risk entirely, since sporadic cancers can still occur. Family history-based monitoring may still apply.
An inherited cancer risk panel may be appropriate for people who have:
For prevention-oriented people in good health, proactive inherited cancer risk multi-gene panel testing is increasingly recognized as a meaningful step in long-term health planning. Knowing which mutations are present or absent allows for more precisely calibrated monitoring and clinical decisions throughout your lifetime.
The number of genes tested by an inherited cancer risk panel varies by laboratory and panel type.
Panels of 25 to 35 genes are common in clinical practice, covering the most well-characterized hereditary cancer genes with the strongest evidence for clinical action. A genetic counselor can help determine what makes sense for you.
Panels run by CAP-accredited, CLIA-certified laboratories have very high accuracy, often over 99%. Interpretation expertise is equally important.
It depends on how you access testing. Genetic tests directly to consumers are available without a referral but typically have significant limitations, including narrower gene coverage and no genetic counseling.
For clinical-grade testing with an appropriate panel scope, expert interpretation, and a documented plan your physician can act on, the most established routes are a physician referral or a precision health membership program like Kadance, which bundles testing and counseling.
If cancer runs in your family, an inherited cancer risk multi-gene panel is the most efficient way to find out whether an inherited mutation is part of the picture.
Kadance exists to make that knowledge accessible. Members receive hereditary cancer risk testing across 26 clinically actionable genes, genetic counseling to interpret positive results, and a documented plan their physician can act on. The best time to find out is now, while you still have the most options.